Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seasonal Malaria Chemoprevention in Aweil South County, South Sudan
NCT05471544Phase 3Unknown
- Sponsor
- Malaria Consortium
- Start
- Jul 2022
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfadoxine + pyrimethamine, amodiaquine in malaria, sponsored by Malaria Consortium. Status: unknown.
02
Drugs
sulfadoxine + pyrimethamineamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT05471544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05471544.